Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin’s lymphomaDavid Frame, Monalisa Ghosh, Salena Kasha et al.|Frontiers in Immunology|2024Cited by 8